foxo4-dri senolytic or senomorphic Targeting cellular senescence with senotherapeutics: senolytics and senomorphics - Zhang - 2023 - The FEBS Journal Senolytics: charting a new course
Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link FOXO4 DRI Results: What to Expect (2026) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



